Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study

被引:0
|
作者
Ashina, Messoud [1 ,2 ,3 ]
Tepper, Stewart J. [4 ]
Brandes, Jan Lewis [5 ,6 ]
Reuter, Uwe [7 ]
Boudreau, Guy P. [8 ]
Dolezil, David [9 ]
Cheng, Sunfa [10 ]
Leonardi, Dean [10 ]
Lenz, Robert A. [10 ]
Klatt, Jan [11 ]
Mikol, Daniel D. [10 ]
机构
[1] Rigshosp, Danish Headache Ctr, Glostrup, Denmark
[2] Rigshosp, Dept Neurol, Glostrup, Denmark
[3] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark
[4] Geisel Sch Med Dartmouth, Hanover, NH USA
[5] Nashville Neurosci Grp, Nashville, TN USA
[6] Vanderbilt Univ, Sch Neurol, Nashville, TN 37235 USA
[7] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[8] Univ Hosp Ctr Montreal, Neurol Dept, Headache Unit, Montreal, PQ, Canada
[9] DADO Med Sro, Prague Headache Ctr, Prague, Czech Republic
[10] Amgen Inc, Thousand Oaks, CA 91320 USA
[11] Novartis Pharma AG, Basel, Switzerland
来源
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P6
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Results of the Open-Label Extension of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
    Sun, Hong
    Dodick, David W.
    Goadsby, Peter
    Silberstein, Stephen
    Reuters, Uwe
    Ashina, Messoud
    Saper, Joel R.
    Cady, Roger
    Zhang, Feng
    Trotman, Marie-Louise
    Dietrich, Julie
    Lenz, Robert
    HEADACHE, 2015, 55 : 256 - 257
  • [32] A DOUBLE-BLIND PLACEBO-CONTROLLED PROPHYLACTIC STUDY OF FLUNARIZINE (SIBELIUM) IN MIGRAINE
    LOUIS, P
    HEADACHE, 1981, 21 (06): : 235 - 239
  • [33] Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study
    Evers, S
    Vollmer-Haase, J
    Schwaag, S
    Rahmann, A
    Husstedt, IW
    Frese, A
    CEPHALALGIA, 2004, 24 (10) : 838 - 843
  • [34] Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: A double-blind placebo-controlled study
    Palevitch, D
    Earon, G
    Carasso, R
    PHYTOTHERAPY RESEARCH, 1997, 11 (07) : 508 - 511
  • [35] Patient-Reported Outcomes in Chronic Migraine Patients with Prior Prophylactic Treatment Failure Receiving Placebo or Erenumab: Subgroup Analysis of a Pivotal Randomized Study
    Lanteri-Minet, M.
    Buse, D. C.
    Starling, A. J.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, S.
    Desai, P.
    Cheng, S.
    Klatt, J.
    Mikol, D.
    HEADACHE, 2018, 58 : 170 - 171
  • [36] Reducing the impact of migraine on functioning: Results from the STRIVE trial, a phase 3, randomised, double-blind, placebo-controlled study of erenumab in patients with episodic migraine
    Buse, Dawn C.
    Lipton, Richard B.
    Mikol, Daniel D.
    Thach, Andrew V.
    Desai, Pooja
    Picard, Hernan
    Kubo, Yumi
    Hareendran, Asha
    Kawata, Ariane K.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [37] The Prophylactic Treatment of PEMF in the Refractory Migraine Headache, Double-Blind, Parallel Placebo-Controlled Study
    Hatef, B.
    Majdoleslam, B.
    Toghae, M.
    Hashemirad, F.
    CEPHALALGIA, 2013, 33 (S8) : 98 - 99
  • [38] Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Imai, Noboru
    Matsumori, Yasuhiko
    Tatsuoka, Yoshihisa
    Numachi, Yotaro
    Yoshida, Ryuji
    Peng, Cheng
    Mikol, Daniel D.
    Lima, Gabriel Paiva da Silva
    Cheng, Sunfa
    BRAIN AND BEHAVIOR, 2022, 12 (03):
  • [39] Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
    Noruzzadeh, Rezvan
    Modabbernia, Amirhossein
    Aghamollaii, Vajiheh
    Ghaffarpour, Majid
    Harirchian, Mohammad Hossein
    Salahi, Sarvenaz
    Nikbakht, Nikta
    Noruzi, Nahid
    Tafakhori, Abbas
    HEADACHE, 2016, 56 (01): : 95 - 103
  • [40] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY OF FLOSEQUINAN IN PATIENTS WITH CHRONIC HEART-FAILURE
    PACKER, M
    NARAHARA, KA
    ELKAYAM, U
    SULLIVAN, JM
    PEARLE, DL
    MASSIE, BM
    CREAGER, MA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (01) : 65 - 72